In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Light Sciences Oncology (light-activated cancer drug therapy) raised $40.1mm through a Series C private placement to undisclosed investors. The company is planning to use the proceeds to continue development of its Litx (Light Infusion Therapy) candidate, which is in Phase III for hepatocellular carcinoma and metastatic colorectal cancer. Other Phase III trials are also set for brain cancer, as well as Phase I/II studies for benign prostatic hyperplasia.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?